Literature DB >> 1716412

Ki-67 staining as a means to simplify analysis of tumor cell proliferation.

C L Hitchcock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1716412     DOI： 10.1093/ajcp/96.4.444

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  17 in total

1.  Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.

Authors:  T Tsuji; P Shrestha; K Yamada; H Takagi; F Shinozaki; K Sasaki; K Maeda; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases.

Authors:  M J Edel; J M Harvey; J M Papadimitriou
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Ki-67 expression in pulmonary tumors.

Authors:  Lucian R Chirieac
Journal:  Transl Lung Cancer Res       Date:  2016-10

4.  A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1.

Authors:  H Kreipe; H J Heidebrecht; S Hansen; W Röhlk; M Kubbies; H H Wacker; M Tiemann; H J Radzun; R Parwaresch
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group.

Authors:  Sharon Lim; Mi Ja Lee; Inju Cho; Ran Hong; Sung Chul Lim
Journal:  Oncol Lett       Date:  2015-12-31       Impact factor: 2.967

Review 6.  The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature.

Authors:  J F Reavey-Cantwell; R I Haroun; M Zahurak; R E Clatterbuck; R J Parker; R Mehta; J P Fruehauf; H Brem
Journal:  J Neurooncol       Date:  2001-12       Impact factor: 4.130

7.  Correlation of bcl-2 oncoprotein immunohistochemical expression with proliferation index and histopathologic parameters in colorectal neoplasia.

Authors:  H A Saleh; H Jackson; G Khatib; M Banerjee
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

8.  Preclinical pharmacokinetic and pharmacodynamic evaluation of novel anticancer agents, ON01910.Na (Rigosertib, Estybon™) and ON013105, for brain tumor chemotherapy.

Authors:  Silpa Nuthalapati; Qingyu Zhou; Ping Guo; Hua Lv; Stephen Cosenza; M V Ramana Reddy; E Premkumar Reddy; James M Gallo
Journal:  Pharm Res       Date:  2012-06-08       Impact factor: 4.200

9.  The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.

Authors:  Yuya Yoshida; Mitsutoshi Nakada; Tomoya Harada; Shingo Tanaka; Takuya Furuta; Yasuhiko Hayashi; Daisuke Kita; Naoyuki Uchiyama; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

10.  MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia.

Authors:  I Chowers; N Livni; A Solomon; G Zajicek; J Frucht-Pery; R Folberg; J Pe'er
Journal:  Br J Ophthalmol       Date:  1998-11       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.